Lack of α-synuclein increases amyloid plaque accumulation in a transgenic mouse model of Alzheimer's disease
<p>Abstract</p> <p>α-synuclein is a small soluble, cytosolic protein which associates with vesicular membranes. It is a component of intracellular Lewy bodies present in Parkinson's disease and a subset of Alzheimer's disease (AD). In addition, early studies identified a...
Main Authors: | Peethumnongsin Erica, Kallhoff Verena, Zheng Hui |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-03-01
|
Series: | Molecular Neurodegeneration |
Online Access: | http://www.molecularneurodegeneration.com/content/2/1/6 |
Similar Items
-
Time course and progression of wild type α-Synuclein accumulation in a transgenic mouse model
by: Amschl David, et al.
Published: (2013-01-01) -
Quinacrine directly dissociates amyloid plaques in the brain of 5XFAD transgenic mouse model of Alzheimer’s disease
by: Sohui Park, et al.
Published: (2021-06-01) -
Intranasal Delivery of Collagen-Loaded Neprilysin Clears Beta-Amyloid Plaques in a Transgenic Alzheimer Mouse Model
by: Christian Humpel
Published: (2021-04-01) -
Lentivirus-Carried microRNA-195 Rescues Memory Deficits of Alzheimer’s Disease Transgenic Mouse by Attenuating the Generation of Amyloid Plaques
by: Dan Su, et al.
Published: (2021-04-01) -
Lack of Nigral Pathology in Transgenic Mice Expressing Human α-Synuclein Driven by the Tyrosine Hydroxylase Promoter
by: Yasuji Matsuoka, et al.
Published: (2001-06-01)